Kashmira Gander
12/10/19
The U.S. Food and Drug Administration (FDA) is investigating whether a drug used to treat diabetes is contaminated with traces of a chemical thought to increase the risk of developing cancer.
The federal agency is working with companies to test samples of metformin sold in the U.S. for the carcinogen N-Nitrosodimethylamine (NDMA), according to a statement from Dr. Janet Woodcock, the director of the FDA's Center for Drug Evaluation and Research. Levels above the daily intake of 96 nanograms are considered unsafe in the U.S.
Metformin, a prescription drug used to control blood sugar levels in type 2 diabetes patients, will be pulled from the market if high levels of NDMA are found.
Keep reading: https://www.newsweek.com/fda-investi...l-ndma-1476380